This document provides an overview of competitive US House races for the 2018 midterm elections that will indicate whether Democrats are having a good night in their goal of taking back the House majority. Key races to watch are listed for New York, Pennsylvania, Illinois, Minnesota, California and other states. Winning toss-up seats will be important for Democrats, while winning tilts and likely Republican districts would signal a strong Democratic wave. The document also promotes the work of the American Academy of Family Physicians in bringing its members together with legislators to advance its policy agenda.
2017.04.06 how should we elect our leadersNUI Galway
Dr Ashley Piggins, Economics, gave this talk entitled "How should we elect our leaders?" on behalf of the Group Decision Making research cluster as part of the 2017 Whitaker Institute Research Day on the 6th of April 2017 at NUI Galway.
This slide deck accompanies my paper of the same title.
Not unlike the paper, I was bound by the contraints of the assignment; therefore, our presentations had to follow a very specific set of guidelines. The research paper is the "meat and potatoes", but I felt compelled to share the supporting presentation.
2017.04.06 how should we elect our leadersNUI Galway
Dr Ashley Piggins, Economics, gave this talk entitled "How should we elect our leaders?" on behalf of the Group Decision Making research cluster as part of the 2017 Whitaker Institute Research Day on the 6th of April 2017 at NUI Galway.
This slide deck accompanies my paper of the same title.
Not unlike the paper, I was bound by the contraints of the assignment; therefore, our presentations had to follow a very specific set of guidelines. The research paper is the "meat and potatoes", but I felt compelled to share the supporting presentation.
It's also ironic considering this is a Republican National Committeesponsored debate,
an RNC Trump has stacked with loyalists. Instead, as he's done before, Trump will be
counterprogramming this Fox News debate, appearing instead in an interview that is
set to air at the same time as the debate with Tucker Carlson, the form
If you love the latest gossip, rumor, and blatant political innuendo when it comes to Indiana politics, then you will love this free edition of The Cheat Sheet.
It's also ironic considering this is a Republican National Committeesponsored debate,
an RNC Trump has stacked with loyalists. Instead, as he's done before, Trump will be
counterprogramming this Fox News debate, appearing instead in an interview that is
set to air at the same time as the debate with Tucker Carlson, the form
If you love the latest gossip, rumor, and blatant political innuendo when it comes to Indiana politics, then you will love this free edition of The Cheat Sheet.
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
QA Paediatric dentistry department, Hospital Melaka 2020Azreen Aj
QA study - To improve the 6th monthly recall rate post-comprehensive dental treatment under general anaesthesia in paediatric dentistry department, Hospital Melaka
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
We understand the unique challenges pickleball players face and are committed to helping you stay healthy and active. In this presentation, we’ll explore the three most common pickleball injuries and provide strategies for prevention and treatment.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Navigating the Health Insurance Market_ Understanding Trends and Options.pdfEnterprise Wired
From navigating policy options to staying informed about industry trends, this comprehensive guide explores everything you need to know about the health insurance market.
16. 16
ELECTION NIGHT BINGO
Watch these House races for a good signal of what kind of night Democrats are
having. Dems must win the Toss-up seats to have a shot at taking the House majority.
If Dems start winning the Tilts and Likely Republican seats, it’s a tsunami
New York
Competitive races: 5
Target Democratic gain for a majority: 2
Key Races: Rep. Claudia Tenney (R-22, TU);
Rep. John J. Faso (R-19, TU); Rep. John Katko (R-
24, LR); Rep. Dan Donovan (R-11, LR); Rep. Chris
Collins (R-27, LR)
Pennsylvania
Competitive races: 9
Target Democratic gain for a majority: 4
Key Races: Open 5th Meehan (LD); Open 6th Costello
(LD); Open 7th Dent (TD); Rep. Keith Rothfus (R-17) vs.
Rep. Conor Lamb (D; LeD); Rep. Brian Fitzpatrick (R-1,
TR); Rep. Scott Perry (R-10, LR); Rep. Mike Kelly (R-16,
LR).Possible R pick-ups: Open 14th; Rep. Matt
Cartwright (D-8, LD).
Illinois
Competitive races: 3
Target Democratic gain for a majority: 2
Key Races: Rep. Peter Roskam (R-6, TU); Rep. Mike
Bost (R-12, TR); Rep. Rodney Davis (R-13, LR)
Minnesota
Competitive races: 5
Target Democratic gain for a majority: 1
Key Races: Rep. Jason Lewis (R-2nd; TU); Rep. Erik
Paulsen (R- 3rd; TR)
Possible R pick-ups: Open 1st Walz (TU); Open 8th
Nolan (TU)
17. 17
ELECTION NIGHT BINGO
Watch these House races for a good signal of what kind of night Democrats are
having. Dems must win the Toss-up seats to have a shot at taking the House majority.
If Dems start winning the Tilts and Likely Republican seats, it’s a tsunami
California
Competitive races: 9
Target Democratic gain for a majority: 5
Key Races: Open 49th Issa (TD); Open 39th Royce (TU); Rep. Dana Rohrabacher (R-48; TU); Rep.
Jeff Denham (R-10, TR); Rep. Steve Knight (R-25, TR); Rep. Mimi Walters (R- 45, TR); Rep. Tom
McClintock (R-4, LR), Rep. David Valadao (R-21, LR), Rep. Duncan Hunter (R-50, LR)
Others to Watch
Kentucky-06: Rep. Andy Barr (R) vs. Amy McGrath (D)
Indiana Senate: Sen. Joe Donnelly (D) vs. Mike Braun (R)
Virginia-07: Rep. Dave Brat (R) vs. Abigail Spanberger (D)
Florida-27: Donna Shalala (D) vs. Maria Elvira Salazar (R)
Arizona Senate: Rep. Martha McSally (R) vs. Rep. Kyrsten Sinema (D)
Texas Senate: Rep. Beto O’Rourke (D) vs. Sen. Ted Cruz (R)
21. Above: AAFP members, Drs. Jay Lee (far left) and
Lisa Ward with Sen. Diane Feinstein (D-CA)
Below: Dr. Jason Dees with
Cindy Hyde-Smith (R-MS)
Below: Dr. Robert Bourne with
Rep. Pete Aguilar (D-CA)
Above: Dr. Karen Smith with
Rep. David Rouzer (R-NC)
Bringing AAFP members and legislators together